Related Experiment Video
Updated: Jul 16, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
High-Dose Insulin for Hyperkalemic Cardiac Arrest
Mohammed A Shikhooun1, Loai A Abdulhadi2, Wael M Yafes3
1Department of Anesthesia, El Galaa Military Medical Complex, El-Orouba, Sheraton Al Matar, El Nozha, Cairo Governorate, Egypt.
Insights
Diagnosing hyperkalemic cardiac arrest is challenging. This study shows high-dose intravenous insulin can help patients survive cardiac arrest caused by high potassium levels.
Area of Science:
- Cardiology
- Emergency Medicine
- Nephrology
Background:
- Hyperkalemic cardiac arrest presents diagnostic and management challenges.
- Restoring normal cardiac rhythm is often delayed until potassium levels decrease.
- Current treatments can be slow to reduce potassium levels.
Purpose of the Study:
- To describe the successful management of hyperkalemic cardiac arrest using high-dose intravenous insulin.
- To highlight an alternative treatment approach for hyperkalemic cardiac arrest.
Main Methods:
- Case report of two patients with witnessed hyperkalemic cardiac arrest.
- Management included conventional advanced cardiac life support.
- Unconventionally high doses of intravenous insulin were administered.
Main Results:
- Both patients survived the witnessed hyperkalemic cardiac arrest.
- High-dose insulin contributed to the successful resuscitation.
- This approach may expedite potassium level normalization.
Conclusions:
- High-dose intravenous insulin can be a life-saving intervention in hyperkalemic cardiac arrest.
- This strategy may offer a faster alternative to conventional treatments.
- Further research is warranted to explore optimal dosing and efficacy.
Abstract:
Hyperkalemic cardiac arrest diagnosis can be elusive and management difficult as the cardiac rhythm restoration is often not achieved until the potassium level decreases to a relatively normal level for the patient who suffers the arrest. Current treatment modalities can take hours to achieve this goal. We describe two patients who survived a witnessed hyperkalemic cardiac arrest after being managed with conventional advanced cardiac life support and unconventionally high doses of intravenous insulin.
Related Concept Videos
Heart Failure Drugs: Inotropic Agents
Cardiopulmonary Resuscitation IV: Pharmacological Management
Acute Kidney Injury V: Interprofessional Care
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Hypoglycemia and Glucagon
Cardiomyopathy II: Dilated Cardiomyopathy

